References
- American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th Edn. American Psychiatric Association, Washington, DC.
- Center on Alcohol and Substance Abuse (1994). Cigarettes, Alcohol, Marijuana: Gateways to Illicit Drug Use. Columbia University, New York.
- Cohen, P.D.A. and Sas, A. (1998). Cannabis Use in Amsterdam. Centre for Drug Research, University of Amsterdam.
- Cohen, P.D.A. and Kaal, H.L. (2001). The Irrelevance of Drug Policy: Patterns and Careers of Experienced Cannabis Use in the Populations of Amsterdam, San Francisco and Bremen. Centre for Drug Research, University of Amsterdam.
- Decorte, T. (2000). The Taming of Cocaine: Cocaine Use in European and American Cities. VUB University Press, Brussels.
- Erickson, P.G. (1982). Illicit drug use, peer attitudes, and perceptions of harmful effects among convicted can- nabis offenders. The International Journal of the Addictions, 17(1),141–154.
- Erickson, P.G. (1993). Prospects of harm reduction for psychostimulants. In: Heather, N., Wodak, A., Nadelmann, E. and O’Hare, P. (Eds.), Psychoactive Drugs and Harm Reduction: From Faith to Science, pp. 184–210. Whurr Publishers, London.
- Erickson, P.G. (1997). The harm minimization option for cannabis: history and prospects in Canadian drug policy. In: Harrison, L. and Inciardi, J. (Eds.), Harm Reduction, pp. 155–169. Sage, London.
- Erickson, P.G., Adlaf, E.M., Smart, R.G. and Murray, G.F. (1994). The Steel Drug: Cocaine and Crack in Perspective, 2nd Edn. Maxwell Macmillan Canada, Toronto.
- Hall, W. (1997). The recent Australian debate about the prohibition on cannabis use. Addiction, 92, 1109–1115.
- Hall, W. (1998). The respiratory risks of cannabis smoking. Addiction, 93, 1461–1464. Hall, W. and Solowij, N. (1998). Adverse effects of cannabis. Lancet, 352, 1611–16l6.
- Hathaway, A.D. (1997a). Marijuana and tolerance: revisiting Becker’s sources of control. Deviant Behavior, 18(2),103–124.
- Hathaway, A.D. (1997b). Marijuana and lifestyle: exploring tolerable deviance. Deviant Behavior, 18(3),213–232.
- Hawks, D. (1993). Impediments to the global adoption of harm-reduction policies. In: Heather, N., Wodak, A., Nadelmann, E. and O’Hare, P. (Eds.), Psychoactive Drugs and Harm Reduction: From Faith to Science, pp. 93–102. Whurr Publishers, London.
- Morgan, J.P., Riley, D. and Chesher, G.B. (1993). Cannabis: legal reform, medicinal use and harm reduction. In: Heather, N. Wodak, A. Nadelmann, E. and O’Hare, P. (Eds.), Psychoactive Drugs and Harm Reduction: From Faith to Science, pp. 211–229. Whurr Publishers, London.
- Morningstar, P. and Chitwood, D. (1983). The Patterns of Cocaine Use. An Interdisciplinary Study. National Institute on Drug Abuse, Rockvil1e, MD.
- Reinarman, C., Cohen, P., Sas, A., Boellinger, L. and Quensel, S. (2000). Is availability destiny? Drug use prevalence and discontinuance in Amsterdam, San Francisco and Bremen. Paper presented at the 11th International Conference on the Reduction of Drug-Related Harm, St. Helier, Jersey, Channel Islands, April 9–13, 2000.
- Strang, J., Witton, J. and Hall, W. (2000). Improving the quality of the cannabis debate: defining the different domains. British Medical Journal, 320, 108–110.
- Tashkin, D.P., Coulson, A., Clark, V.A.L., Simmons, M., Bourque, L.B., Duann, S., Spivey, G.M. and Gong, H. (1987). Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and non-smokers. American Review of Respiratory Disease, 135, 209–216.
- World Health Organization, Programme on Substance Abuse (1997). Cannabis: A Health Perspective and Research Agenda. Division of Mental Health and Prevention of Substance Abuse, WHO, Geneva.
- Zinberg, N.E. (1984). Drug, Set, and Setting: The Basis for Controlled Intoxicant Use. Yale University Press, New Haven, Connecticut.